BioSpace News Archive

Press Releases

Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025

September 30, 2025
·
9 min read
Press Releases

Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US

September 30, 2025
·
9 min read
Press Releases

Boehringer Ingelheim launches new direct-to-consumer platform to expand patient access to important treatments

September 30, 2025
·
4 min read
Press Releases

Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer

September 30, 2025
·
2 min read
Press Releases

Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025

September 30, 2025
·
12 min read
Press Releases

Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide

September 30, 2025
·
7 min read
Press Releases

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

September 30, 2025
·
10 min read
Press Releases

D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program

September 30, 2025
·
5 min read
Press Releases

Novartis announces commencement of tender offer to acquire Tourmaline Bio

September 30, 2025
·
9 min read
Press Releases

Kedrion Biopharma Receives FDA Approval for QIVIGY® (Immune Globulin 10% IV) for treatment of Primary Humoral Immunodeficiency in Adults and confirms its plan to increase investments in the U.S. throughout its global operations.

September 30, 2025
·
11 min read